Stockscreener 앱 받기
21.86
2.58%
0.55
Azenta Inc 주식(AZTA)의 최신 뉴스
Azenta: Life Science Player Fails To Come To Life (NASDAQ:AZTA) - Seeking Alpha
Congress Asset Management Co. Invests $42.76 Million in Azenta, Inc. $AZTA - MarketBeat
Contrasting Azenta (NASDAQ:AZTA) & Talkspace (NASDAQ:TALK) - Defense World
Trading Recap: Is Azenta Inc stock trending bullishForecast Cut & Free Reliable Trade Execution Plans - baoquankhu1.vn
Needham reiterates Azenta stock rating citing growth drivers By Investing.com - Investing.com Australia
Azenta's (AZTA) Buy Rating Reiterated at Needham & Company LLC - MarketBeat
Needham reiterates Azenta stock rating citing growth drivers - Investing.com
Needham Reiterates Buy Rating on Azenta (AZTA) with Price Target of $44 | AZTA Stock News - GuruFocus
Azenta (NASDAQ:AZTA) Hits New 1-Year LowHere's What Happened - MarketBeat
Azenta Details UK Biocentre Buyout to Expand Europe Biobanking, Near-Term EBITDA Dilution Seen - Yahoo Finance
Azenta stock hits 52-week low at $22.44 By Investing.com - Investing.com India
Azenta stock hits 52-week low at $22.44 - Investing.com
Azenta, Inc. (AZTA) Uk Biocentre LimitedM&A CallSlideshow (NASDAQ:AZTA) 2026-03-10 - Seeking Alpha
Azenta Announces Fiscal 2024 Second Quarter Earnings Conference Call and Webcast - GuruFocus
Aug Reactions: Can Azenta Inc sustain earnings growthMarket Volume Report & Smart Allocation Stock Tips - baoquankhu1.vn
Tenet Healthcare, Revvity, Avantor, Azenta, and Elanco Shares Plummet, What You Need To Know - Yahoo Finance
GW&K Investment Management LLC Has $32.47 Million Stake in Azenta, Inc. $AZTA - MarketBeat
Osborne Clarke advises shareholders of UK Biocentre on sale to Azenta Life Sciences - Osborne Clarke
Azenta Acquires UK Biocentre to Expand European Biorepository - The Globe and Mail
Azenta Details Turnaround at Raymond James Conference, Targets Margin Gains and Recurring Revenue Growth - MarketBeat
Investor Mood: Is Azenta Inc stock trending bullish2025 Support & Resistance & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Fisher Asset Management LLC Sells 48,408 Shares of Azenta, Inc. $AZTA - MarketBeat
AZTA Technical Analysis & ETF Price Forecast - Intellectia AI
Azenta acquires UK Biocentre for £20.5 million By Investing.com - Investing.com Canada
Azenta acquires UK Biocentre for £20.5 million - Investing.com South Africa
Azenta completes strategic acquisition of UK Biocentre Limited, to expand biorepository capabilities - marketscreener.com
Azenta to Acquire UK Biocentre for GBP 20.5 Million to Build European SRS Hub - TradingView
Azenta (AZTA) acquires UK Biocentre in GBP 20.5m European hub deal - Stock Titan
Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities - marketscreener.com
Vanguard Group Inc. Lowers Holdings in Azenta, Inc. $AZTA - MarketBeat
Azenta, Inc. (AZTA) Presents at 47th Annual Raymond James Institutional Investor ConferenceSlideshow - Seeking Alpha
Royce & Associates LP Has $9.88 Million Position in Azenta, Inc. $AZTA - MarketBeat
How The Azenta (AZTA) Story Is Shifting With Analyst Rethinks And New Buyback Plan - Yahoo Finance
Azenta, Inc. (NASDAQ:AZTA) Short Interest Update - MarketBeat
Azenta stock hits 52-week low at 23.88 USD By Investing.com - Investing.com Canada
Azenta at 47th Annual Raymond James Conference: Strategic Turnaround Insights - Investing.com Australia
Azenta (NASDAQ:AZTA) Hits New 12-Month LowHere's What Happened - MarketBeat
AZTA SEC FilingsAzenta Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Azenta stock hits 52-week low at 23.88 USD - Investing.com South Africa
Azenta, Inc. (AZTA) Stock Analysis: Unveiling a 49.64% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Azenta, Inc. (NASDAQ:AZTA) Given Average Rating of "Hold" by Brokerages - MarketBeat
AZTA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Fulgent Genetics and Azenta Compared as Investments - National Today
Rate Hike: Can Azenta Inc keep up with sector leaders2025 Trading Volume Trends & Breakout Confirmation Alerts - baoquankhu1.vn
Azenta, Inc. (AZTA) Investor Outlook: Exploring a 37.95% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
0.95%
0.04%
자본화:
|
볼륨(24시간):